The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 21, 2017
Filed:
Oct. 31, 2013
Applicant:
Oncomed Pharmaceuticals, Inc., Redwood City, CA (US);
Inventors:
Steven Eugene Benner, Seattle, WA (US);
Robert Joseph Stagg, Moraga, CA (US);
Jakob Dupont, Hillsborough, CA (US);
Assignee:
ONCOMED PHARMACEUTICALS, INC., Redwood City, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/50 (2006.01); A61K 39/395 (2006.01); C07K 16/30 (2006.01); G01N 33/574 (2006.01); G01N 33/68 (2006.01); A61K 31/282 (2006.01); A61K 31/706 (2006.01); G01N 33/74 (2006.01); A61K 31/4045 (2006.01);
U.S. Cl.
CPC ...
G01N 33/57488 (2013.01); A61K 31/282 (2013.01); A61K 31/4045 (2013.01); A61K 31/706 (2013.01); A61K 39/39558 (2013.01); C07K 16/30 (2013.01); G01N 33/6893 (2013.01); G01N 33/74 (2013.01); G01N 2333/58 (2013.01); G01N 2800/32 (2013.01); G01N 2800/52 (2013.01);
Abstract
Methods for treating diseases such as cancer comprising administering a DLL4 antagonist, either alone or in combination with other anti-cancer agents, and monitoring for cardiovascular side effects and/or toxicity.
Benner, Steven. (2017). Methods and monitoring of treatment with a dll4 antagonist (U.S. Patent No. 9599620). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9599620
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile